KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

Authors
Astrid LièvreJean‐Baptiste BachetPierre Laurent‐Puig
Journal
Journal of Clinical Oncology
Published
January 17, 2008
Sign in to comment
Add a comment...

No comments yet. Start the conversation!

Your contribution could help open science.

Supporters

Support the authors with ResearchCoin

Topics

DOI

10.1200/jco.2007.12.5906

License

Unknown License
KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab - Comments